Literature DB >> 2841488

Alternate mRNA splicing is required for synthesis of adeno-associated virus VP1 capsid protein.

J P Trempe1, B J Carter.   

Abstract

Fine-structure mapping of the capsid-specific mRNAs from adeno-associated virus (AAV) revealed an alternate splicing pattern in these RNAs. S1 nuclease and primer extension analyses showed that splicing of these mRNAs occurs at acceptor sites at nucleotide 2228 (major splice) or 2201 (minor splice). Both splice acceptors were ligated to the same 55-nucleotide leader in mature mRNAs. Both species were present in equal amounts in mRNA derived from AAV plasmid-transfected cells. However, when adenovirus infection accompanied the DNA transfection, the major splice predominated over the minor splice. Using cDNA clones of both the major and minor spliced mRNAs, we demonstrated that the largest AAV capsid protein, VP1, was derived from the minor spliced mRNA. The other capsid proteins, VP2 and VP3, came predominantly from the major spliced mRNA. These results, which describe the previously undetected minor splice, provide a mechanism for the production of all three AAV virion proteins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841488      PMCID: PMC253458          DOI: 10.1128/JVI.62.9.3356-3363.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  32 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Adeno-associated virus autointerference.

Authors:  B J Carter; C A Laughlin; L M de la Maza; M Myers
Journal:  Virology       Date:  1979-01-30       Impact factor: 3.616

3.  Regulation of adeno-associated virus gene expression in 293 cells: control of mRNA abundance and translation.

Authors:  J P Trempe; B J Carter
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

4.  Spliced adenovirus-associated virus RNA.

Authors:  C A Laughlin; H Westphal; B J Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

5.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

6.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Definition of a novel promoter for the major adenovirus-associated virus mRNA.

Authors:  M R Green; R G Roeder
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

9.  Transcripts of the adeno-associated virus genome: mapping of the major RNAs.

Authors:  M R Green; R G Roeder
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

10.  Adenovirus helper function for growth of adeno-associated virus: effect of temperature-sensitive mutations in adenovirus early gene region 2.

Authors:  M W Myers; C A Laughlin; F T Jay; B J Carter
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

View more
  60 in total

1.  Adeno-associated virus RNAs appear in a temporal order and their splicing is stimulated during coinfection with adenovirus.

Authors:  M B Mouw; D J Pintel
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses.

Authors:  Jianming Qiu; Ramnath Nayak; Gregory E Tullis; David J Pintel
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size.

Authors:  G E Tullis; T Shenk
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 4.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

5.  Structural Studies of AAV2 Rep68 Reveal a Partially Structured Linker and Compact Domain Conformation.

Authors:  Faik N Musayev; Francisco Zarate-Perez; Martino Bardelli; Clayton Bishop; Emil F Saniev; R Michael Linden; Els Henckaerts; Carlos R Escalante
Journal:  Biochemistry       Date:  2015-09-14       Impact factor: 3.162

6.  Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein.

Authors:  D M McCarty; M Christensen; N Muzyczka
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

7.  Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene Therapy.

Authors:  William B Guggino; Liudmila Cebotaru
Journal:  Hum Gene Ther       Date:  2020-05       Impact factor: 5.695

8.  Identification of a heparin-binding motif on adeno-associated virus type 2 capsids.

Authors:  A Kern; K Schmidt; C Leder; O J Müller; C E Wobus; K Bettinger; C W Von der Lieth; J A King; J A Kleinschmidt
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein.

Authors:  S R Kyöstiö; R S Wonderling; R A Owens
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins.

Authors:  Q Yang; F Chen; J P Trempe
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.